Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies
Clinical trial NCT00001261 · COMPLETED
Trial details
- NCT number
- NCT00001261
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1990-05-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.